| Literature DB >> 20354269 |
Irina A Vinogradova1, Vladimir N Anisimov, Andrey V Bukalev, Viktor A Ilyukha, Evgeniy A Khizhkin, Tatiana A Lotosh, Anna V Semenchenko, Mark A Zabezhinski.
Abstract
We evaluated the effect of exposure to constant light started at the age of 1 month and at the age of 14 months on the survival, life span, tumorigenesis and age-related dynamics of antioxidant enzymes activity in various organs in comparison to the rats maintained at the standard (12:12 light/dark) light/dark regimen. We found that exposure to constant light started at the age of 1 month accelerated spontaneous tumorigenesis and shortened life span both in male and female rats as compared to the standard regimen. At the same time, the exposure to constant light started at the age of 14 months failed to influence survival of male and female rats. While delaying tumors in males, constant light accelerated tumors in females. We conclude that circadian disruption induced by light-at-night started at the age of 1 month accelerates aging and promotes tumorigenesis in rats, however failed affect survival when started at the age of 14 months. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.Entities:
Mesh:
Substances:
Year: 2010 PMID: 20354269 PMCID: PMC2850144 DOI: 10.18632/aging.100120
Source DB: PubMed Journal: Aging (Albany NY) ISSN: 1945-4589 Impact factor: 5.682
Effect of the exposure to constant light started at the age of 1 month (LL-1) and at the age of 14 months (LL-14) on survival and life span in male rats.
Notes: * Number of rats at the age of 14 months. Difference with controls (LD) is significant: a, p< 0.05; b, p< 0.01; #, in brackets 95% confidential intervals. MRDT, mortality rate doubling time.
| Parameters | Light/dark regimen | ||
| LD | LL-1 | LL-14 | |
| Number of rats* | 43 | 34 | 90 |
| Mean life span, days | 766 ± 25.4 | 744 ± 28.0 | 818 ± 18.1 (+ 6.7%) |
| Maximum life span, days | 1045 | 1005 | 1141 |
| Mean life span of last 10% survivors, days | 994 ± 9.2 | 1002 ± 1.8 | 1087 ± 8.3 (+ 9.4%)b |
| α x 103, days-1 | 7.49 (7.20; 7.75)# | 7.07 (6.90; 7.16)a | 6.58 (6.28; 6.82)a |
| MRDT, days | 92.6 (89.4; 96.3) | 98.1 (96.9; 100.4)a | 105.3 (101.6; 110.4.)a |
Figure 1.Effect of the exposure to various light regimens on tumorigenesis and survival in rats.
(A) - survival, males; (B) - total tumor incidence, males; (C) - fatal tumor incidence, males; (D) - survival, females; (E) - total tumor incidence, females; (F) - fatal tumor incidence, females.
Effect of the exposure to constant light started at the age of 1 month (LL-1) and at the age of 14 months (LL-14) on survival and life span in female rats.
Notes: * Number of rats at the age of 14 months. Difference with controls (LD) is significant: a, p<0.05; b, p<0.01; #, in brackets 95% confidential intervals. MRDT, mortality rate doubling time.
| Parameters | Light/dark regimen | ||
| LD | LL-1 | LL-14 | |
| Number of rats* | 30 | 36 | 71 |
| Mean life span, days | 844 ± 33.6 | 658 ± 22.8b (- 22.0%) | 811 ± 20.0 |
| Maximum life span, days | 1167 | 956 | 1198 |
| Mean life span of last 10% survivors, days | 1129 ± 18.9 | 921 ± 19.7 (-18.4%) | 1113 ± 24.9 |
| α x 103, days-1 | 5.74 (5.56; 6.01) | 4.19 (4.01; 4.38)a | 6.03 (5.79; 6.35) |
| MRDT, days | 120.7 (115.3; 124.6) | 165.6 (158.4; 173.1)a | 114.9 (109.1; 119.6) |
Cox's regression model parameters for experimental groups.
| All rats | β | exp(β) | se(β) | p |
| Males LL-1 and LL-14 | -0.41 | 0.67 | 0.25 | 1.00E-01 |
| Females LD and LL-1 | 1.02 | 2.78 | 0.34 | 2.30E-03 |
| Females LL-1 and LL-14 | -0.82 | 0.44 | 0.26 | 1.70E-03 |
Effect of the exposure to constant light started at the age of 1 month (LL-1) and at the age of 14 months (LL-14) on tumorigenesis in male rats.
Notes: TBR - tumor-bearing rats.
| Parameters | Light/dark regimen | ||
| LD | LL-1 | LL-14 | |
| Number of rats | 43 | 34 | 90 |
| Number of TBR (%) | 15 (34.9%) | 12 (35.3%) | 26 (28.9%) |
| Number of malignant TBR (%) | 8 (18.6%) | 10 (29.4%) | 9 (10%) |
| Total number of tumors | 21 | 13 | 34 |
| Number of tumors per TBR | 1.40 | 1.08 | 1.31 |
| Age at the time of the 1st tumor detections, days | 600 | 428 | 469 |
| Mean life span of TBR, days | 849 ± 34.7 | 786 ± 65.3 | 897 ± 32.1 |
| Mean life span of fatal TBR, days | 821 ± 52.2 | 794 ± 72.8 | 879 ± 62.5 |
| Testes: Leydigoma hemangioma | 7 | 3 | 16 |
| 1 | - | 1 | |
| Malignant lymphoma/ leukemia | 3 | 6 | 3 |
| Mammary gland: fibroadenoma | - | - | 1 |
| Liver: hepatocarcinoma | 2 | 2 | 1 |
| Skin carcinoma | - | - | 1 |
| Soft trissues: angiofibroma fibroma chondroma sarcoma malignant fibrous histoiocytoma | - | - | 1 |
| - | - | 1 | |
| - | - | 1 | |
| - | - | 4 | |
| 2 | - | - | |
| Lung: adenocarcinoma light-c ell carcinoma | - | 1 | - |
| 1 | - | - | |
| Small bowel: adenocarcinoma | - | 1 | - |
| Adrenal gland: cortical adenoma pheochromocytoma | 3 | - | 3 |
| 1 | - | - | |
| Urether: fibroma | 1 | - | - |
| Nervous system: paraganglioma | - | - | 1 |
| Total: benign malignant | 13 | 3 | 25 |
| 8 | 10 | 9 | |
Effect of the exposure to constant light started at the age of 1 month (LL-1) and at the age of 14 months (LL-14) on tumorigenesis in female rats.
Notes: TBR - tumor-bearing rats.
| Parameters | Light/dark regimen | ||
| LD | LL-1 | LL-14 | |
| Number of rats | 30 | 36 | 71 |
| Number of TBR (%) | 17 (56.7%) | 20 (55.6%) | 30 (45.3) |
| Number of malignant TBR (%) | 1.47 | 1.75 | 1.37 |
| Total number of tumors | 5 (16.7%) | 5 (13.9%) | 11 (15.5%) |
| Number of tumors per TBR | 25 | 35 | 41 |
| Age at the time of the 1st tumor detections, days | 562 | 550 | 565 |
| Mean life span of TBR, days | 871 ± 51.4 | 732 ± 28.8 | 885 ± 29.3 |
| Mean life span of fatal TBR, days | 1098 ± 21.8 | 758 ± 52.0 | 868 ± 47.3 |
| Mammary gland: fibroma fibroadenoma adenocarcinoma | 2 | - | 2 |
| 11 | 19 | 25 | |
| - | 1 | - | |
| No of rats with benign mammary tumors | 12 (40.0%) | 16 (44.4%) | 19 (26.8%) |
| Utery: polyp fibroma fibromyoma adenocarcinoma | 2 | 4 | - |
| 1 | 1 | - | |
| - | 1 | - | |
| - | 1 | 1 | |
| Skin: fibroma | - | - | 1 |
| Adrenal gland: cortical adenoma pheochromocytoma | 1 | 3 | 2 |
| 2 | - | - | |
| Ovary: fibroma | 1 | - | - |
| Pituitary: adenoma | - | 1 | - |
| Malignant lymphoma/ leukemia | 3 | 2 | 7 |
| Soft tissues: fibroma sarcoma | - | 1 | - |
| 2 | 1 | 2 | |
| Lung: adenocarcinoma | - | - | 1 |
| Total: benign malignant | 20 | 30 | 30 |
| 5 | 5 | 11 | |
Multifactor analysis of variance (MANOVA) evaluation of various factors effect on activity of antioxidant enzymes (Data represented as % of factors influences, F-ratio and p value).
Notes: Only significant data are presented. Empty columns means the absence of effect of a factor on enzyme activity.
| Age | Season | Light regimen | Time of the start of exposure to the constant light | |
| Liver | 9.1% 11.01 0.0016 | 25.5% 26.02 0.0001 | ||
| Heart | 17.6% 6.67 0.0025 | |||
| Lungs | 11.5% 3.90 0.026 | |||
| Skeletal muscle | 11.7% 3.85 0.027 | |||
| Liver | 9.1% 15.2 0.0003 | 30.8% 25.58 0.0001 | 20.1% 33.34 0.0001 | 32.2% 53.47 0.0001 |
| Kidney | 14.0% 7.84 0.001 | |||
| Skeletal muscle | 23.0% 20.99 0.0001 | 8.0% 3.65 0.03 | ||